Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 62 Records) |
| Query Trace: Neoplasms and FOXA1[original query] |
|---|
| Characterization of Stromal Tumor-infiltrating Lymphocytes and Genomic Alterations in Metastatic Lobular Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 9 26 (23): 6254-6265. Richard François, Majjaj Samira, Venet David, Rothé Françoise, Pingitore Julien, Boeckx Bram, Marchio Caterina, Clatot Florian, Bertucci François, Mariani Odette, Galant Christine, Eynden Gert van den, Salgado Roberto, Biganzoli Elia, Lambrechts Diether, Vincent-Salomon Anne, Pruneri Giancarlo, Larsimont Denis, Sotiriou Christos, Desmedt Christi |
| Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib. Frontiers in oncology 2020 6 10 729. Yuan Bo, Zhao Jun, Zhou Chengzhi, Wang Xiumei, Zhu Bo, Zhuo Minglei, Dong Xilin, Feng Jiemei, Yi Cuihua, Yang Yunpeng, Zhang Hua, Zhou Wangyan, Chen Zhengtang, Yang Sheng, Ai Xinghao, Chen Kehe, Cui Xuefan, Liu Difa, Shi Chunmei, Wu Wei, Zhang Yanjun, Chang Lianpeng, Li Jin, Chen Rongrong, Yang Shuanyi |
| Association of Genetic Polymorphisms in FOXA1 with the Progression of Genetic Susceptibility to Gastric Cancer. Gastroenterology research and practice 2020 2020 3075837. Ding Guo-Wen, Gu Xu-Yu, Dai Zhe, Pan Hui-Wen, Wang Xiao-Yan, Zhang Heng, Fan |
| NCOR1 may be a potential biomarker of a novel molecular subtype of prostate cancer. FEBS open bio 2020 Oct . Tang Lu, Zhang Lixia, Liu Lei, Dong Liping, Dong Yuan, Zhu Wenhe, Wang Huiy |
| Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility. Nature communications 2021 9 12 (1): 5318. Wen Wanqing, Chen Zhishan, Bao Jiandong, Long Quan, Shu Xiao-Ou, Zheng Wei, Guo Xing |
| Parallel Reporter Assays Identify Altered Regulatory Role of rs684232 in Leading to Prostate Cancer Predisposition. International journal of molecular sciences 2021 8 22 (16): . Ren Naixia, Liu Qingqing, Yan Lingjie, Huang Qil |
| FOXA1 mutations influence the therapeutic response of breast cancer by altering chromatin state. Molecular & cellular oncology 2021 5 8 (3): 1891831. Arruabarrena-Aristorena Amaia, Toska Ene |
| Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis. Cancer discovery 2021 4 11 (8): 2094-2111. Kim Michael P, Li Xinqun, Deng Jenying, Zhang Yun, Dai Bingbing, Allton Kendra L, Hughes Tara G, Siangco Christian, Augustine Jithesh J, Kang Ya'an, McDaniel Joy M, Xiong Shunbin, Koay Eugene J, McAllister Florencia, Bristow Christopher A, Heffernan Timothy P, Maitra Anirban, Liu Bin, Barton Michelle C, Wasylishen Amanda R, Fleming Jason B, Lozano Guillermi |
| Epidemiology and genomics of prostate cancer in Asian men. Nature reviews. Urology 2021 Mar . Zhu Yao, Mo Miao, Wei Yu, Wu Junlong, Pan Jian, Freedland Stephen J, Zheng Ying, Ye Dingw |
| The ADRB1 (Adrenoceptor Beta 1) and ADRB2 genes significantly co-express with commonly mutated genes in prostate cancer. Discovery medicine 0 30 (161): 163-171. Lehrer Steven, Rheinstein Peter |
| FOXA1 of regulatory variant associated with risk of breast cancer through allele-specific enhancer in the Chinese population. Breast cancer (Tokyo, Japan) 2021 Oct . Li Bin, Cheng Xiang, Zhu Ying, Wan Hao, Lu Zequn, Cai Yimin, Li Wenhui, Yi Pengfei, Liu Li, Chang Jiang, Miao Xiaoping, Tian Jianbo, Zhong Ro |
| Genome-Wide Analysis Unveils DNA Helicase RECQ1 as a Regulator of Estrogen Response Pathway in Breast Cancer Cells. Molecular and cellular biology 2021 1 41 (4): . Lu Xing, Redon Christophe E, Tang Wei, Parvathaneni Swetha, Bokhari Bayan, Debnath Subrata, Li Xiao Ling, Muys Bruna R, Song Young, Pongor Lorinc S, Sheikh Omar, Green Andrew R, Madhusudan Srinivasan, Lal Ashish, Ambs Stefan, Khan Javed, Aladjem Mirit I, Sharma Sud |
| Endometrial Cancer in Aspect of Forkhead Box Protein Contribution. International journal of environmental research and public health 2022 8 19 (16): . Adamczyk-Gruszka Olga, Horecka-Lewitowicz Agata, Gruszka Jakub, Wawszczak-Kasza Monika, Strzelecka Agnieszka, Lewitowicz Pio |
| Mutator-Derived lncRNA Landscape: A Novel Insight Into the Genomic Instability of Prostate Cancer. Frontiers in oncology 2022 7 12 876531. Tang Liansha, Li Wanjiang, Xu Hang, Zheng Xiaonan, Qiu Shi, He Wenbo, Wei Qiang, Ai Jianzhong, Yang Lu, Liu Jiy |
| Genomic features of Chinese small cell lung cancer. BMC medical genomics 2022 May 15 (1): 117. Liu Jun, Zhao Zhuxiang, Wei Shuquan, Li Binkai, Zhao Ziw |
| Analysis of BRCA Germline Mutations in Chinese Prostate Cancer Patients. Frontiers in oncology 2022 3 12 746102. Chen Wei, Xia Wei, Xue Song, Huang Hang, Lin Qi, Liu Yi, Liu Tongtong, Zhang Yiqun, Zhang Panwang, Wang Jianfei, Yang Yining, Dong Baijun, Yu Zhixi |
| Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity. Molecular oncology 2023 8 . Yu Wei, Tingwei Zhang, Beihe Wang, Jian Pan, Shengming Jin, Bangwei Fang, Weijie Gu, Xiaojian Qin, Bo Dai, Guowen Lin, Hualei Gan, Junlong Wu, Dingwei Ye, Yao Z |
| Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients. European journal of medical research 2023 7 28 (1): 239. Bin Lang, Chen Cao, Xiaoxiao Zhao, Yi Wang, Ying Cao, Xueying Zhou, Tong Zhao, Yuyan Wang, Ting Liu, Wenjia Liang, Zheng Hu, Xun Tian, Jingjing Zhang, Yongji Y |
| Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. Anticancer research 2023 6 43 (7): 2941-2949. Christian Rocca, Giulia Rocca, Pietro Zampieri, Lucio Dell'atti, Nicoletta Bianchi, Carmelo Ippolito, Gianluca Aguia |
| Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors. Urologic oncology 2023 4 . Alshalalfa Mohammed, Goglia Alexander G, Swami Nishwant, Nguyen Bastien, Hougen Helen Y, Khan Anwar, Kishan Amar U, Punnen Sanoj, Nguyen Paul L, Mahal Brandon A, Dee Edward Christoph |
| Determination of TMPRSS2-ERG, SPOP, FOXA1, and IDH1 prostate cancer molecular subtypes in Colombian patients and their possible implications for prognosis. Cell biology international 2023 2 . Montero-Ovalle Wendy, Sanabria-Salas María C, Mesa-López de Mesa Jorge, Varela-Ramírez Rodolfo, Segura-Moreno Yenifer Y, Sánchez-Villalobos Santiago A, Nuñez-Lemus Marcela, Serrano Martha |
| Unravelling the Role of Iroquois Homeobox 4 and its Interplay with Androgen Receptor in Prostate Cancer. Research square 2023 12 . Jyotsna Batra, Janaththani Panchadsaram, Gregor Tevz, Achala Fernando, Adil Malik, Anja Rockstroh, Thomas Kryza, Carina Walpole, Leire Moya, Melanie Lehman, Colleen Nelson, The Australian Prostate Cancer BioResource, The Practical Consortium, Srilakshmi Sriniva, Judith Clemen |
| Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel. Annals of medicine 2023 11 55 (2): 2280708. Kangpeng Yan, Li Niu, Boyu Wu, Chongwu He, Lei Deng, Chuan Chen, Zhangzhang Lan, Chao Lin, Weihua Kuang, Huihong Lin, Jun Zou, Wenyong Zhang, Zhiqiang L |
| Changes in cell-free DNA after short-term palbociclib and fulvestrant treatment for advanced or metastatic hormone receptor-positive and human epidermal growth factor 2-negative breast cancer. Breast cancer research and treatment 2023 10 . Takayuki Iwamoto, Naoki Niikura, Kenichi Watanabe, Takashi Takeshita, Yuichiro Kikawa, Kokoro Kobayashi, Nobutaka Iwakuma, Takuho Okamura, Hiroshi Tada, Shinji Ozaki, Toshitaka Okuno, Uhi Toh, Yutaka Yamamoto, Michiko Tsuneizumi, Hiroshi Ishiguro, Norikazu Masuda, Shigehira Sa |
| Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis. Urologic oncology 2023 10 . Mohammed Al-Toubat, Samuel Serrano, Ahmed Elshafei, Kashyap Koul, Allison H Feibus, K C Bala |
| Polymorphisms within autophagy-related genes as susceptibility biomarkers for pancreatic cancer: A meta-analysis of three large European cohorts and functional characterization. International journal of cancer 2024 9 . Fernando Gálvez-Montosa, Giulia Peduzzi, José Manuel Sanchez-Maldonado, Rob Ter Horst, Antonio J Cabrera-Serrano, Manuel Gentiluomo, Angelica Macauda, Natalia Luque, Pelin Ünal, Francisco Javier García-Verdejo, Yang Li, José Antonio López López, Angelika Stein, H Bas Bueno-de-Mesquita, Paolo Giorgio Arcidiacono, Dalila Luciola Zanette, Christoph Kahlert, Francesco Perri, Pavel Soucek, Renata Talar-Wojnarowska, George E Theodoropoulos, Jakob R Izbicki, Hussein Tamás, Hanneke Van Laarhoven, Gennaro Nappo, Maria Chiara Petrone, Martin Lovecek, Roel C H Vermeulen, Kestutis Adamonis, Fernando Jesus Reyes-Zurita, Bernd Holleczek, Jolanta Sumskiene, Beatrice Mohelníková-Ducho?ová, Rita T Lawlor, Raffaele Pezzilli, Mateus Nobrega Aoki, Claudio Pasquali, Vitalija Petrenkiene, Daniela Basso, Stefania Bunduc, Annalisa Comandatore, Hermann Brenner, Stefano Ermini, Giuseppe Vanella, Mara R Goetz, Livia Archibugi, Maurizio Lucchesi, Faik Guntac Uzunoglu, Olivier Busch, Anna Caterina Milanetto, Marta Puzzono, Juozas Kupcinskas, Luca Morelli, Cosimo Sperti, Silvia Carrara, Gabriele Capurso, Casper H J van Eijck, Martin Oliverius, Susanne Roth, Francesca Tavano, Rudolf Kaaks, Andrea Szentesi, Ludmila Vodickova, Claudio Luchini, Ben Schöttker, Stefano Landi, Orsolya Dohan, Matteo Tacelli, William Greenhalf, Maria Gazouli, John P Neoptolemos, Giulia Martina Cavestro, Ugo Boggi, Anna Latiano, Péter Hegyi, Laura Ginocchi, Mihai G Netea, Pedro Sánchez-Rovira, Federico Canzian, Daniele Campa, Juan Sai |
| Pan-cancer genomic analysis reveals FOXA1 amplification is associated with adverse outcomes in non-small cell lung, prostate, and breast cancers. Journal of the National Cancer Institute 2024 9 . Alexander G Goglia, Mohammed Alshalalfa, Anwar Khan, Danielle R Isakov, Helen Y Hougen, Nishwant Swami, Jasmine Kannikal, Sean M Mcbride, Daniel R Gomez, Sanoj Punnen, Paul L Nguyen, Puneeth Iyengar, Emmanuel S Antonarakis, Brandon A Mahal, Edward Christopher D |
| Clinical implications of Wnt pathway genetic alterations in men with advanced prostate cancer. Prostate cancer and prostatic diseases 2024 7 . Amanda Broderick, Elizabeth Pan, Jinju Li, Alec Chu, Clara Hwang, Pedro C Barata, Frank Cameron Cackowski, Matthew Labriola, Alyssa Ghose, Mehmet Asim Bilen, Deepak Kilari, Bicky Thapa, Michael Piero, Laura Graham, Abhishek Tripathi, Rohan Garje, Vadim S Koshkin, Erik Hernandez, Tanya B Dorff, Michael Thomas Schweizer, Ajjai Shivaram Alva, Rana R McKay, Andrew J Armstro |
| Spatial architectures of somatic mutations in normal prostate, benign prostatic hyperplasia and coexisting prostate cancer. Experimental & molecular medicine 2024 1 . Jeesoo Chae, Seung-Hyun Jung, Eun Ji Choi, Jae Woong Kim, Na Yung Kim, Sung Won Moon, Ji Youl Lee, Yeun-Jun Chung, Sug Hyung L |
| XRCC1 rs1799782 Promotes DNA Damage Repair in Lung Cancer Cells by Enhancing Its Binding to FOXA1 to Facilitate FOXA1-Mediated Transcription of XRCC1. Discovery medicine 2024 1 36 (180): 82-90. Cunlai Xu, Yuling Li, Jiongwei Pan, Shuanghu Wang, Zaiting Ye, Xiaoping Cai, Hao Zheng, Zhangyong Yin, Zhuo C |
- Page last reviewed:Feb 1, 2024
- Content source: